EQT to shed $1.2bn of shares in Swiss skincare firm
Sale of around 13 million shares is being coordinated by Goldman Sachs, Morgan Stanley and UBS
Sale of around 13 million shares is being coordinated by Goldman Sachs, Morgan Stanley and UBS
Amundi and Columbia Threadneedle join Goldman Sachs AM among the group winners
Carmignac and Columbia Threadneedle join Goldman Sachs AM among the group winners
Carmignac and Columbia Threadneedle join Goldman Sachs AM among the group winners
The acquisition will expand MSIM’s fixed income and ESG capabilities
As coronavirus bites many investors may look to shield portfolios by moving into defensive assets
Managers will have to shrink core active offer as revenues fall warns Oliver Wyman/Morgan Stanley report
Emerging market equity funds winners when it comes to three-year performance and sustainability
We compare two top global equity funds: Morgan Stanley Global Opportunity Fund and Threadneedle Global Focus Fund
Investing with a conscience is fully compatible with generating attractive long term returns, according to Morgan Stanley Investment Management (MSIM).
Billions flowed into European ethical funds over the last year but scratch beneath the surface and the sector is being held back by a lack of clarity over what it stands for.
Morgan Stanley Investment Management (MSIM) is to offer access to its well-established China A-shares fund through a Luxembourg-domiciled Sicav.